You are here: Industry Insights > Gates Foundation

News List

Gates Foundation supports HIV and malaria research pharmatimes
January 15, 2022
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation to include the advancement of new innovations for HIV and malaria treatment.
Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts prnasia
September 23, 2021
New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals.
Novartis, Gates Foundation to Develop Accessible Gene Therapy for Sickle Cell Disease americanpharmaceuticalreview
February 20, 2021
Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation. As part of the agreement, the foundation will provide funding support for the discovery and development of a single-administration, in vivo gene therapy to cure SCD.
Gates Foundation offers $70 mn additional funding for COVID-19 vaccines expresspharma
November 13, 2020
$50 million will go to the COVAX Advance Market Commitment (AMC) and $20 million to the Coalition for Epidemic Preparedness Innovations (CEPI).
Wellcome, Gates Foundation, Mastercard focus on Covid-19 therapies pharmaceutical-technology
March 12, 2020
Wellcome has partnered with the Bill & Melinda Gates Foundation and Mastercard to provide up to $125m of seed funding to accelerate the development of Covid-19 therapies.
Gates Foundation’s $100M-a-year nonprofit biotech takes flight fiercebiotech
June 11, 2018
The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute (MRI) will turn drug industry expertise a
Gates Foundation supports development of Immunocore’s therapeutics for infectious diseases pharmaceufical-technology
September 20, 2017
Immunocore is a UK-based company focused on developing biological therapies for the treatment of cancer, infectious diseases and autoimmune diseases.
Gates Foundation commits $120M for nonprofit PATH's vaccine work fiercepharma
September 07, 2017
RELATED: PATH, research institutes to test novel malaria vaccine in humans
Achaogen Receives Investment from Gates Foundation americanpharmaceuticalreview
May 09, 2017
Achaogen announced it has signed an agreement with the Bill & Melinda Gates Foundation to prevent neonatal sepsis in developing countries through the generation of monoclonal antibodies against gram-negative bacteria.
Canada’s AbCellera receives grant from Gates Foundation to help fight tuberculosis pharmaceutical-technology
January 24, 2017
Canadian-based AbCellera has received a grant from the Bill & Melinda Gates Foundation to help fight tuberculosis.